The treatment combines a new drug, inavolisib, with two older breast cancer drugs, fulvestrant (Faslodex ®) and palbociclib (Ibrance ®) . Inavolisib, which targets PIK3CA mutations, appears to be a ...
Treatment for breast cancer starts with a correct diagnosis. We’re here to help you take the first steps toward getting the best cancer care. You may be reading this because you’re thinking about ...
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to ...